Analysis of proteome changes in doxorubicin-treated adult rat cardiomyocyte

Journal of Proteomics

Volumn 74, Issue 5, 2011, Pages 683-697

  Kumar, Suresh N ^a   Konorev, Eugene A ^b   Aggarwal, Deepika ^c   Kalyanaraman, Balaraman ^d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF HAWAII AT HILO   (United States)

^c DR REDDY'S LABORATORIES LTD   (India)

^d FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

Cardiomyopathy; Doxorubicin; Proteomics

Indexed keywords

DOXORUBICIN; METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE (ACYLATING); PROTEOME; VOLTAGE DEPENDENT ANION CHANNEL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CONTROLLED STUDY; HEART MUSCLE CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEOMICS; RAT; SOLUBILIZATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CARDIOMYOPATHIES; CARDIOTOXINS; DOXORUBICIN; GENE EXPRESSION REGULATION; MALE; MUSCLE PROTEINS; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TIME FACTORS;

RATTUS;

EID: 79953309047     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.02.013     Document Type: Article

References (76)

1. Singal P.K., Iliskovic N. Doxorubicin induced cardiomyopathy. N Engl J Med 1998, 339:900-905.
2. Kremer L.C., Van Dalen E.C., Offringa M., Ottenkamp J., Voute P.A. Anthracycline induced clinical heart failure in a cohort of 607 children: long term follow up study. J Clin Oncol 2001, 19:191-196.
3. Kawasaki N., Lee J.D., Shimizu H., Ueda T. Long term l-carnitine treatment prolongs the survival in rats with adriamycin induced heart failure. J Card Fail 1996, 2:293-299.
4. Powis G. Free radical formation by anti tumor quinones. Free Radic Biol Med 1989, 6:63-101.
5. Myers C.E., McGuire R.H., Liss R.H., Ifrim I., Grotzinger K., Young R.C. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 1977, 197:165-167.
6. Andrieu-Abadie N., Jaffrezou J., Hatem S., Laurent G., Levade T., Mercadier J. L-carnitine prevents doxorubicin induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J 1999, 13:1501-1510.
7. Konorev E.A., Kotamraju S., Zhao H., Kalivendi S., Joseph J., Kalyanaraman B. Paradoxical effects of metalloporphyrins on doxorubicin induced apoptosis. scavenging of reactive oxygen species versus induction of heme oxygenase-1. Free Radic Biol Med 2002, 33:988-997.
8. Adachi K., Fujiura Y., Mayumi F., Nozuhara A., Sugiu Y., Sakanashi T., et al. A deletion of mitochondrial DNA in murine doxorubicin induced cardiotoxicity. Biochem Biophys Res Commun 1993, 195:945-951.
9. Zhou S., Starkov A., Froberg M.K., Leino R.L., Wallace K.B. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res 2001, 61:771-777.
10. Lebrecht D., Setzer B., Ketelsen U.P., Haberstroh J., Walker U.A. Time dependent and tissue specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation 2003, 108:2423-2429.
11. Davies K.J., Doroshow J.H. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem 1986, 261:3060-3067.
12. Jung K., Reszka R. Mitochondria as sub cellular targets for clinically useful anthracyclines. Adv Drug Deliv Rev 2001, 49:87-105.
13. Vasquez-Vivar J., Martasek P., Hogg N., Masters B.S., Pritchard K.A., Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycine. Biochemistry 1997, 36:11293-11297.
14. Minotti G., Cairo G., Monti E. Role of iron in anthracycline cardiotoxicity: new tunes for an old song?. FASEB J 1999, 13:199-212.
15. Kalyanaraman B., Joseph J., Kalivendi S., Wang S., Konorev E., Kotamraju S. Doxorubicin induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 2002, 234-235:119-124.
16. Doroshow J.H., Davis K.J. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide and hydroxyl radical. J Biol Chem 1986, 261:3068-3074.
17. Winterbourn C.C., Gutteridge J.M.C., Halliwell B. Doxorubicin-dependent lipid peroxidation at low partial pressure of O2. J Free Radic Biol Med 1985, 1:43-49.
18. Gille L., Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic Biol Med 1997, 23:775-782.
19. Torti F.M., Torti S.V. Regulation of ferritin genes and protein. Blood 2002, 99:3505-3516.
20. Brazzolotto X., Gaillard J., Pantopoulos K., Hentze M.W., Moulis J.M. Human cytoplasmic aconitase (Iron regulatory protein 1) is converted into its [3Fe-4S] form by hydrogen peroxide in vitro but is not activated for iron responsive element binding. J Biol Chem 1999, 274:21625-21630.
21. Minotti G., Recalcati S., Liberi G., Calafiore A.M., Mancuso C., Preziosi P., et al. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J 1998, 12:541-552.
22. Minotti G., Ronchi R., Salvatorelli E., Menna P., Cairo G. Doxorubicin irreversibly inactivates iron regulatory protein 1 and 2 in cardiomyocytes. Evidence for distinct metabolic pathways and implications for iron mediated cardiotoxicity of antitumor therapy. Cancer Res 2001, 61:8422-8428.
23. Tobin T.P., Abbot B.C. A stereological analysis of the effect of adriamycin on the ultrastructure of rat myocardial cells in culture. J Mol Cell Cardiol 1980, 12:1207-1225.
24. Kumar D., Kirshenbaum L., Li T., Danelisen I., Singal P. Apoptosis in isolated adult cardiomyocytes exposed to adriamycin. Ann N Y Acad Sci 1999, 874:156-168.
25. Li T., Danelisen I., Bello-Klein A., Singal P.K. Effect of probucol on changes of antioxidant enzymes in adriamycin induced cardiomyopathy in rats. Cardiovasc Res 2000, 46:523-530.
26. Heon S., Bernier M., Servant N., Dostanic S., Wang C., Kirby G.M., et al. Dexrazoxane does not protect against doxorubicin induced damage in the young rat. Am J Physiol Heart Circ Physiol 2003, 285:H499-H506.
27. Lawenda B.D., Kelly K.M., Ladas E.J., Sagar S.M., Vickers A., Blumberg J.B. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?. J Natl Cancer Inst 2008, 100:773-783.
28. Block K.I., Koch A.C., Mead M.N., Tothy P.K., Newman R.A., Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer 2008, 123:1227-1239.
29. Ito H., Miller S.C., Billingham M.E., Akimoto H., Torti S.V., Wade R., et al. Doxorubicin selectivity inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc Natl Acad Sci 1990, 87:4275-4279.
30. Jeyaseelan R., Poizat C., Baker R.K., Abdishoo S., Isterabadi L.B., Lyons G.E., et al. A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J Biol Chem 1997, 272:22800-22808.
31. Jeyaseelan R., Poizat C., Wu H.Y., Kedes L. Molecular mechanisms of doxorubicin induced cardiomyopathy. Selective suppression of Reiske iron sulfur protein, ADP/ATP translocase and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes. J Biol Chem 1997, 272:5828-5832.
32. Cutts S.M., Parsons P.G., Strum R.A., Phillips D.R. Adriamycin induced DNA adducts inhibit DNA interactions of transcription factors and RNA polymerase. J Biol Chem 1996, 271:5422-5429.
33. Wang S., Kotamraju S., Konorev E., Kalivendi S., Joseph J., Kalyanaraman B. Activation of nuclear factor-kappaB during doxorubicin induced apoptosis in endothelial cells and myocytes is proapoptotic: the role of hydrogen peroxide. Biochem J 2002, 367:729-740.
34. Gigli M., Doglia S.M., Millot J.M., Valentini L., Manfait M. Quantitative study of doxorubicin in living cell nuclei by microspectrofluorometry. Biochim Biophys Acta 1988, 950:13-20.
35. L'Ecuyer T., Sanjeev S., Thomas R., Novak R., Das L., Cambell W., et al. DNA damage is an early event in doxorubicin induced cardiac myocyte death. Am J Physiol Heart Circ Physiol 2006, 291:H1273-H1280.
36. Ellis C.N., Ellis M.B., Blakemore W.S. Effect of adriamycin on heart mitochondrial DNA. Biochem J 1987, 245:309-312.
37. Piper H.M., Volz A., Schwartz P. Adult ventricular rat heart cells. Cell Culture Techniques in Heart and Vessel Research 1990, 36-60. Springer Verlag, Heidelberg. H.M. Piper (Ed.).
38. Hohl C.M., Altschuld R.A., Brierley G.P. Effects of calcium on the permeability of isolated adult rat heart cells to sodium. Arch Biochem Biophys 1982, 221:197-205.
39. Armstrong S.C., Ganote C.E. Effects of 2,3-butanedione monoxime (BDM) on contracture and injury of isolated rat myocytes following metabolic inhibition and ischemia. J Mol Cell Cardiol 1991, 23:1001-1014.
40. Konorev E.A., Kennedy M.C., Kalyanaraman B. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin induced cardiotoxicity. The role of reactive oxygen and nitrogen intermediates. Arch Biochem Biophys 1999, 368:421-428.
41. Kotamraju S., Konorev E.A., Joseph J., Kalyanaraman B. Doxorubicin induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem 2000, 275:33585-33592.
42. Gharahdaghi F., Weinberg C.R., Meagher D.A., Imai B.S., Mische S.M. Mass spectrometric identification of proteins from silver stained polyacrylamide gels: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20:601-605.
43. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
44. Nagi M.N., Mansour M.A. Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol Res 2000, 41:283-289.
45. Kim Y.K., Lee W.K., Jin Y., Lee K.J.H., Yu Y.G. Doxorubicin binds to un-phosphorylated form of hNopp 140 and reduces protein kinase CK2-dependent phosphorylation of hNopp140. J Biochem Mol Biol 2006, 39:774-781.
46. Green P.S., Leeuwenburgh C. Mitochondrial dysfunction is an early indicator of doxorubicin induced apoptosis. Biochim Biophys Acta 2002, 1588:94-101.
47. Tokarska-Schlattner M., Dolder M., Gerber I., Speer O., Wallimann T., Schlattner U. Reduced creatine stimulated respiration in doxorubicin challenged mitochondria: particular sensitivity of the heart. Biochim Biophys Acta 2007, 1767:1276-1284.
48. Salvatorelli E., Guarnieri S., Menna P., Liberi G., Calafiore A.M., Mariggio M.A., et al. Defective one- and two-electron reduction of the anticancer anthracycline epirubicin in human heart. Relative importance of vesicular sequestration and impaired efficiency of electron addition. J Biol Chem 2006, 281:10990-11001.
49. Zhou S., Palmeira C.M., Wallace K.B. Doxorubicin induced persistent oxidative stress to cardiac myocytes. Toxicol Lett 2001, 121:151-157.
50. Romisch J., Grote M., Weithmann K.U., Heimburger N., Amann E. Annexin protein PP4 and PP4-X: comparative characterization of biological activities of placental and recombinant proteins. Biochem J 1990, 272:223-229.
51. Strauss H.W., Narula J., Blankenberg F. Radioimaging to identify myocardial cell death and probably injury. Lancet 2000, 356:180-181.
52. Andree H.A., Reutelingsperger C.P., Hauptmann R., Hemker H.C., Hermens W.T., Willems G.M. Binding of vascular anticoagulant (VAC) to planar phospholipid bilayers. J Biol Chem 1990, 265:4923-4928.
53. Ray P.S., Martin J.L., Swanson E.A., Otani H., Dillmann W.H., Das D.K. Transgene over expression of alpha B crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J 2001, 15:393-402.
54. Klemenz R., Frohli E., Steiger R.H., Schafer R., Aoyama A. Alpha B-crystallin is a small heat shock protein. Proc Natl Acad Sci 1991, 88:3652-3656.
55. Abdel-aleem S., el-Merzabani M.M., Syed-ahmed M., Taylor D.A., Lowe J.E. Acute and chronic effects of adriamycine on fatty acid oxidation in isolated cardiac myocytes. J Mol Cell Cardiol 1997, 29:789-797.
56. Hong Y.M., Kim H.S., Yoon H.R. Serum lipid and fatty acid profiles in adriamycine treated rats after administration of l-carnitine. Pediatr Res 2002, 51:249-255.
57. Zong H., Ren J.M., Young L.H., Pypaert M., Mu J., Birnbaum J., et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci 2002, 99:15983-15987.
58. Berthiaume L., Deichaite I., Peseckis S., Resh M.D. Regulation of enzymatic activity by active site fatty acylation. A new role for long chain fatty acid acylation of proteins. J Biol Chem 1994, 269:6498-6505.
59. Kanski J., Behring A., Pelling J., Schoeneich C. Proteomic identification of 3-nitrotyrosine containing rat cardiac proteins. Effects of biological aging. Am J Physiol Heart Circ Physiol 2005, 288:H371-H381.
60. Pacher P., Liaudet L., Bai P., Virag L., Mabley J.G., Hasko G., et al. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J Pharmacol Exp Ther 2002, 300:862-867.
61. Mukhopadhyay P., Rajesh M., Batkai S., Kashiwaya Y., Hasko G., Liaudet L., et al. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and invitro. Am J Physiol Heart Circ Physiol 2009, 296:H1466-H1483.
62. Arai M., Tomaru K., Takizawa T., Sekiguchi K., Yokoyama T., Suzuki T., et al. Sarcoplasmic reticulum genes are selectively downregulated in cardiomyopathy produced by doxorubicin in rabbits. J Mol Cell Cardiol 1998, 30:243-254.
63. Turakhia S., Venkatakrishnan C.D., Dunsmore K., Wong H., Periannan K., Zweier J.L., et al. Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblasts and H9c2 cells survival and aconitase activity with heat shock protein 27. Am J Physiol Heart Circ Physiol 2007, 293:H3111-H3121.
64. O'Callaghan-Sunol C., Gabai V.L., Sherman M.Y. Hsp27 modulates p53 signaling and suppresses cellular senescence. Cancer Res 2007, 67:11779-11788.
65. Arrigo A.P., Landry J. Expression and function of the low molecular weight heat shock proteins. The biology of heat shock proteins and molecular chaperones 1994, Vol. 26:335-373. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. R.I. Morimoto, A. Tissieres, C. Georgopoulos (Eds.).
66. Venkatakrishnan C.D., Tewari A.T., Moldovan L., Cardounel A.J., Zweier J.L., Kuppuswamy P., et al. Heat shock protects cardiac cells from doxorubicin induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27. Am J Physiol Heart Circ Physiol 2006, 291:H2680-H2691.
67. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., Lesnefsky E.J. Production of reactive oxygen species by mitochondria. Central role of complex III. J Biol Chem 2003, 278:36027-36031.
68. Young T.A., Cunningham C.C., Bailey S.M. Reactive oxygen species production by the mitochondrial respiratory chain in isolated rat hepatocytes and liver mitochondria: studies using myxothiazol. Arch Biochem Biophys 2002, 405:65-72.
69. Bordoni A., Biagi P., Hrelia S. The impairment of essential fatty acid metabolism as a key factor in doxorubicin induced damage in cultured rat cardiomyocytes. Biochim Biophys Acta 1999, 1440:100-106.
70. Chernyak B.V. Redox regulation of the mitochondrial permeability transition pore. Biosci Rep 1997, 17:293-302.
71. Cheng E.H., Sheiko T.V., Fisher J.K., Craigen W.J., Korsmeyer S.J. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 2003, 301:513-517.
72. Ren D., Kim H., Tu H.C., Westergard T.D., Fisher J.K., Rubens J.A., et al. The VDAC2-BAK rheostat controls thymocyte survival. Sci Signal 2009, 2:ra48.
73. Roy S.S., Ehrlich A.M., Craigen W.J., Hajnoczky G. VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to mitochondria. EMBO Rep 2009, 10:1341-1347.
74. Yamagata H., Shimizu S., Nishida Y., Watanabe Y., Craigen W.J., Tsujimoto Y. Requirement of voltage-dependent anion channel 2 for pro-apoptotic activity of Bax. Oncogene 2009, 28:3563-3572.
75. Sarioglu H., Brandner S., Haberger M., Jacobsen C., Lichtmannegger J., Wormke M., et al. Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced proteome changes in 5L rat hepatoma cells reveals novel targets of dioxin action including the mitochondrial apoptosis regulator VDAC2. Mol Cell Proteomics 2008, 7:394-410.
76. Konorev E.A., Vanamala S., Kalyanaraman B. Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes. Free Radic Biol Med 2008, 45:1723-1728.